Abdulrahim Mohammed Basendwah (Abdulrahim M Basendwah)

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Osman Omer Radhwi, Maha Abdulrazak Badawi, Adel Almarzouki, Fakhr Al-Ayoubi, Ghada Elgohary, Kazi Nur Asfina, Abdulrahim Mohammed Basendwah, Iman Ayed Alhazmi, Eiman A Almahasnah, Ahmed Al Bahrani, Abdulrahman Al Raizah, Ayel Yahya, Khadeja Alshahrani, Salwa I Hindawi
A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry. Journal of clinical apheresis (2023)
Mauricio Fernandes, Magdalena Schelotto, Philipp Maximilian Doldi, Giovanna Milani, Abul Andrés Ariza Manzano, Doriam Perera Valdivia, Alexandra Marie Winter Matos, Yasmin Hamdy Abdelrahim, Shaza Ahmed Hamad Bek, Benito K Benitez, Vanessa Luiza Romanelli Tavares, Abdulrahim Mohammed Basendwah, Luis Henrique Albuquerque Sousa, Naiara Faria Xavier, Tania Zertuche Maldonado, Sarah Toyomi de Oliveira, Melisa Chaker, Michelle Menon Miyake, Elif Uygur Kucukseymen, Kinza Waqar, Ola M J Alkhozondar, Ricardo Bernardo da Silva, Guilhermo Droppelmann, Antonio Vaz de Macedo, Rui Nakamura, Felipe Fregni
IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain. F1000Research 10 (2021)

Abdulrahim Mohammed Basendwah.css-eqlu8i{font-size:small;padding-left:4px;} (Abdulrahim M Basendwah)